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Abstract Indoleamine 2,3 dioxygenase (IDO) is a potent
immunomodulatory enzyme that has recently attracted
significant attention for its potential application as an
inducer of immunotolerance in transplantation. We have
previously demonstrated that a collagen matrix populated
with IDO-expressing fibroblasts can be applied successfully
in suppressing islet allogeneic immune response. Meanwhile,
a critical aspect of such immunological intervention relies
largely on effective long-term expression of the IDO gene.
Moreover, gene manipulation of primary cells is known to be
challengingduetounsatisfactoryexpressionofthe exogenous
gene. In this study, a lentiviral gene delivery system has been
employed to transduce primary fibroblasts. We used poly-
brene to efficiently deliver the IDO gene into primary
fibroblasts and showed a significant increase (about tenfold)
in the rate of gene transfection. In addition, by the use of
fluorescence-activated cell sorting, a 95% pure population
of IDO-expressing fibroblasts was successfully obtained.
The efficiency of the IDO expression and the activity of
the enzyme have been confirmed by Western blotting,
fluorescence-activated cell sorting analysis, and Kynurenine
assay, respectively. The findings of this study revealed
simple and effective strategies through which an efficient
and stable expression of IDO can be achieved for primary
cells which, in turn, significantly improves its potential as
a tool for achieving immunotolerance in different types of
transplantation.




Indoleamine 2,3-dioxygenase (IDO) is a monomeric, heme-
containing enzyme that catalyzes the rate limiting step of
conversion of tryptophan to kynurenine [1]. Recently,
tryptophan catabolism has been implicated in immunolog-
ical tolerance. One theory proposes that degradation of
tryptophan suppresses T cell proliferation by reducing the
availability of this essential amino acid in local tissue
environments, thereby sensitizing T cells to apoptosis [2].
Another theory suggests that the major tryptophan metab-
olite, kynurenine, suppresses immune reactivity through
direct interaction with effector T lymphocytes [3]. The
immunomodulatory effects of tryptophan deficiency and
excess kynurenine caused by IDO are of particular interest
in the field of transplantation [4].
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IDO is the requirement to achieve effective expression of
this gene. However, genetic manipulation by non-viral
transfection approaches has been challenging due to the
issues of low transfection efficiency, loss of cell viability,
and difficulty in obtaining stable transfection [5, 6].
Previously, we have shown that by using dermal fibroblasts
transduced with an IDO-expressing adenoviral vector, IDO
functions as a local immunosuppressive factor [7], and local
expression of IDO suppresses islet allogeneic immune
response in mouse islet transplantation [8]. Furthermore,
we have used the local immunosuppressive effect of IDO in
the development of a non-rejectable skin substitute [9].
These findings demonstrate that IDO has considerable
potential for immunoregulation and induction of immuno-
tolerance in transplantation.
Nevertheless, the immunogenicity and transient gene
expression of adenoviral vectors may hinder its clinical use
in transplantation. Thus, in order to sustain the efficacy of
IDO activity in the local environment of transplanted organ,
it is essential to prolong the expression of functional IDO
protein. In fact, it was shown that lentiviral vectors can
maintain efficient long-term target gene expression in vivo
for more than 4 years [10]. It is has been reported that
polybrene can markedly enhance the retrovirus transduction
efficiency [11]. In this report, we constructed an IDO-
expressing lentiviral vector and showed that treatment of
cells with polybrene-enhanced IDO transduction efficiency
almost ten times. To enrich IDO-expressing cells and thereby
optimize transplantation immunotolerance, we selectively
isolated the IDO-positive cells by fluorescence-activated cell
sorting (FACS) and obtained a greater than 95% pure
population of IDO-expressing cells.
2 Materials and Methods
2.1 Plasmid Constructions
A lentiviral construct for expressing the IDO gene was
generated using the pLC-E vector [12] modified from the
lentiviral backbone FUGW [13]. For visualization of the
lentiviral-mediated IDO expression, a sequence encoding
the red fluorescent mCherry protein under the control of the
UbC promoter was incorporated into the vector. The human
IDO gene (NM_002164; a generous gift from Dr. JM Carlin
of Miami University) was generated by PCR using a full-
length cDNA encoding the gene as template and the forward
primer (5′-GGGGACAAGTTTGTACAAAAAAGCAGGCT
TCACCATGGCACACGCTATGGAAAACTCCTGG-3′)
and reverse primer (5′-GGG GACCACTTTGTACAAGAA
AGCTGGGTCCTAACCTTCCTTCAAAAG
GGATTTCTC-3′). The amplified PCR product was first
inserted into an entry vector (pDON201) and then Gateway
(Invitrogen) cloned into a lentiviral pLC-E expression vector.
The IDO gene is expressed under the control of EF1-α
promoter, and the mCherry red fluorescent gene, a reporter
gene, is expressed under the control of a ubiquitin promoter.
The plasmid was amplified in competent DH10-B bacteria
and purified using the Qiagen Plasmid DNA Maxi-prep kit
(Qiagen). Sequence of the IDO/pLC-E construct was con-
firmed by DNA sequencing analysis.
2.2 Cell Culture
Skin samples were collected from 6- to 8-week-old male
C57BL/6 (B6) mice according to the guidelines of the
Animal Policy and Welfare Committee of the University of
British Columbia. The samples were then washed in sterile
dulbecco’s modified eagle medium (DMEM) (Invitrogen
Life Technologies, Carlsbad, CA) supplemented with antibi-
otic–antimycotic preparation [100 U/ml penicillin, 100 mg/ml
streptomycin, 0.25 mg/ml amphotericin B (Invitrogen)].
Cultures of fibroblasts were established as previously described
[14] and grown in DMEM supplemented with 10% fetal
bovine serum (FBS; Invitrogen Life Technologies, Carlsbad,
CA). Confluent cells were released by trypsinization,
reseeded onto 75 cm
2 cell culture flasks (BD Biosciences,
MA), and incubated in a humidified incubator at 37°C
supplied with 5% CO
2. Fibroblasts at passages three to five
were used in all experiments.
2.2.1 Lentiviral Vector Production and Cell Transduction
Replication-defective lentiviral vectors were generated as
previously described [15, 16] by transient transfection of
293T human kidney cells with the IDO/pLC-E vector, R8.9
(packaging plasmid), and VSV-G (envelope plasmid).
Some 293T cells were seeded the night before transfection
in DMEM medium supplemented with 10% fetal bovine
serum (Invitrogen Life Technologies, Carlsbad, CA). The
cells were replaced with DMEM+10% FBS and trans-
fected at 60–70% confluency using ProFectin (Mammalian
Transfection System Calcium Phosphate; Promega). For each
100-mm
2 round plate, 10 µg IDO/pLC-E vector, 7.5 µg R8.9
plasmid, and 2.5 µg VSV-G plasmid were used. The culture
medium was replaced with a fresh medium containing DMEM
and 5% FBS 12–16 h after transfection. Supernatant was
harvested 30 h after the medium change. The vector stocks
were concentrated by centrifugation at 126,000g for 90 min
using Beckman Ultracentrifuge and stored at −80°C until use.
For transduction, 293T cells or mouse fibroblasts
were seeded on flat-bottom 6-well cell culture plates
(Corning Incorporated, Corning, NY, USA) and incubated
with the same titer of IDO-lentiviral vector for 24 h in the
absence or presence of 10 ug/ml polybrene. Cell superna-
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culture 30 h later.
2.3 SDS-PAGE and Western Blotting
For detection of the IDO protein expression, transduced
cells were harvested 24 h post-transduction and washed
twice with PBS. Cells were then lysed in lysis buffer
(50 mM Tris-HCl, pH 7.4; 10 mM EDTA; 5 mM EGTA;
0.5% NP40; 1% Triton X-100; and protease inhibitor cocktail
(Sigma). Equal amounts of total protein from each individual
293T cell culture were separated by 10% sodium dodecyl
sulfate - polyacrylamide gel electrophoresis (SDS-PAGE).
ProteinswerethentransferredtoaPVDFmembrane(Millipore
Corp., Bedford, MA) and immunoblotted with a polyclonal
anti-human IDO antibody (Washington Biotechnology Inc.,
Baltimore, MD) at final dilution of 1:5,000. Horseradish
peroxidase-conjugated goat anti-rabbit IgG was used as the
secondary antibody for the enhanced chemiluminescence
detection system (Amersham Biosciences, UK). Blots were
then stripped and reprobed for β-actin as a control for protein
loading.
2.4 Fluorescence Microscopy
The lentiviral-mediated IDO expression in transduced 293T
cells, and mouse fibroblasts were examined by fluorescence
microscopy with a Zeiss Axiovert 200 M microscope. Images
fromidenticalareasofculturedcellswererecordedusingboth
fluorescence and bright-field microscopy. Images were
captured using Northern Eclipse image analysis software.
2.5 Kynurenine Assay
The biological activity of IDO was evaluated by measuring
the level of tryptophan degradation product, L-kynurenine,
present in the conditioned medium of transduced cells. The
amount of L-kynurenine was measured by a previously
established method [17]. Proteins in the conditioned medium
were precipitated by trichloroacetic acid. After centrifuga-
tion, 0.5 ml of supernatant was incubated with an equal
volume of Ehrlich's reagent at room temperature for 10 min.
The reaction mixture was measured spectrophotometrically
at 490 nm. The concentration of kynurenine in the condi-
tioned medium was calculated according to a standard curve
of defined kynurenine concentration (0–20 mg/ml).
2.6 Flow Cytometry
To determine the transduction efficiency of the IDO-
lentiviral vector, and in order to sort mCherry-positive
cells, non-transduced cultured fibroblasts, fibroblasts trans-
duced with IDO-lentiviral vector in the absence or presence
of polybrene were trypsinized, collected, and centrifuged.
The cell pellet was washed twice with PBS and resuspended
at 10
6 cells/mL for flow cytometry and at 10
7 cells/mL for
sorting in PBS±2% FBS. For flow cytometry, BD LSRII
with 630 LP and 670/30 detectors were used. For sorting,
BDFACSAriawithabluelaserdetectorwasused.Ineachset,
live cells were gated using forward scatter channel vs side
scatter channel followed by gating on the IDO-expressing
mCherry-positive cells. The number of mCherry-positive
cells for fibroblasts transduced with IDO-lentiviral vector in
t h ep r e s e n c eo fp o l y b r e n ea f ter sorting was also deter-
mined by flow cytometry analysis. The average purity
was greater than 95%.
3 Results and Discussion
3.1 Characterization of Lentiviral-Mediated IDO
Expression
Schematic diagram of the IDO–mCherry lentiviral vector is
shown in Fig. 1a. IDO-expressing lentiviral vector prepa-
rations were generated. To examine the efficacy of the
generated lentiviral vector, the vector was first collected
from the transfected 293T cells and used to transduce a
fresh culture of 293T cells. The red fluorescent mCherry
protein acts as a reporter for the promoter activity of the
IDO gene, verifying that the IDO gene is present and
expressed in the transduced cells (Fig. 1b). As shown in
Fig. 1bd, majority of transduced cells express red fluores-
cent mCherry protein as a reporter gene for IDO expression
compared with that of control cells (Fig. 1bb). Figure 1b
panels c and a show the images of the same cells in bright-
field. Furthermore, to examine the protein expression of the
exogenously introduced IDO gene, lysates of the trans-
duced cells were subjected to SDS-PAGE and immuno-
blotted with an anti-IDO polyclonal antibody (Fig. 1c). As
seen in Fig. 1c, the IDO expression was positive in both
viral preparations and the transduction was successful.
Non-transduced cell lysate was used as a negative control
and recombinant IDO protein was used as a positive
control. In order to test whether the overexpressed IDO
protein was functional, kynurenine assay was performed to
measure the concentration of the major tryptophan degra-
dation product (L-kynurenine) in the conditioned media. In
comparison with non-transduced cells, the concentration of
L-kynurenine in the conditioned media of transduced cells
increased nearly threefold (Fig. 1d) and the result was
significantly different from that of non-transduced cells
(P<0.02, n=3). The results show that the IDO-expressing
lentiviral vector generated by transient transfection of 293T
cells was functional and suitable for transduction of primary
fibroblasts.
Efficient Stable Expression of IDO 1093.2 Transduction of Primary Mouse Fibroblasts
with IDO-Expressing Lentiviral Vector
Dermal fibroblasts were transduced with the IDO-
expressing lentiviral vector. To analyze lentiviral-mediated
IDO expression, transduced cells were visualized by
fluorescence microscopy 24 h post-transduction (Fig. 2a).
The Fig. 2a upper and lower panels are bright-field images
and fluorescence images, respectively. Fluorescence images
are images of the same groups of cells captured by the
bright-field microscope, and the fluorescence is due to
expression of the mCherry gene. Figure 2a panels a and e
as well as b and f represent non-transduced fibroblasts and
IDO-lentiviral vector-transduced fibroblasts, respectively.
To facilitate delivery of the IDO-lentiviral vector, polybrene
was added to cells at the time of transduction. The cells
were similarly examined by fluorescence microscopy 48 h
post-transduction (Fig. 2a, panels c and g). Transduced
fibroblasts in the presence of polybrene were gated and
sorted by FACS and examined by fluorescence microscopy
(Fig. 2a, panels d and h). As the fluorescent images show,
the level of mCherry-positive cells increased in the
presence of polybrene and after sorting. The expression of
Fig. 1 Construction of a
lentiviral-based vector for deliv-
ering the IDO gene. a Schematic
diagram of the IDO–mCherry
lentiviral construct. b Fluores-
cence microscopy analysis of
IDO-expressing cells. Panels a
and b as well as c and d represent
bright-field and fluorescent
images of the IDO–mCherry
(red) expression in non-
transduced and transduced 293T
cells, respectively. c Lentiviral
vector-mediated IDO protein
expression in transduced 293T
cells. The arrow on the upper
band shows the IDO protein. The
IDO-lentiviral vector lanes rep-
resent two separate viral prepa-
rations. The blot was reprobed
with a β-actin antibody as a
loading control. d Kynurenine
assay. Functional IDO activity
was evaluated by measuring the
content of kynurenine in the
conditioned media of non-
transduced and IDO-lentiviral
vector-transduced cells. The data
shown are the mean and standard
deviation of kynurenine in
conditioned media of three sepa-
rate experiments
Fig. 2 Transduction of mouse fibroblasts with IDO-expressing
lentiviral vector. a Fluorescence microscopy analysis of IDO-lentiviral
vector-transducedfibroblasts.Cultured mouse fibroblasts were incubated
with IDO-lentiviral vector either in the presence or absence of polybrene.
Cells that were transduced in the presence of polybrene were then sorted
by FACS. Panels a and e, b and f, c and g, as well as d and h represent
bright-field and fluorescence images of non-transduced fibroblasts,
IDO-lentiviral vector-transduced fibroblasts, fibroblasts transduced with
IDO-expressing lentiviral vector in the presence of polybrene, and
fibroblasts transduced with IDO-expressing lentiviral vector in the
presence of polybrene after sorting, respectively. b These panels show
the Western blot analysis (a)a sw e l la sk y n u r e n i n el e v e l s( b) in different
indicated cells. The data shown are the mean and standard deviation of
kynurenine measurements obtained from three different experiments. c
Flow cytometry analysis of the IDO-expressing cell population.
Fibroblasts were left either non-transduced or transduced with IDO-
expressing lentiviral vector in the absence or presence of polybrene and
flow cytometry was then conducted by gating the cells based on their
mCherry fluorescence. The selected cell population was prepared by
cell sorting and the number of mCherry-positive cells was greater
than 95%. Panel a shows non-transduced fibroblasts, b transduced
IDO-expressing fibroblasts in the absence of polybrene, c transduced
IDO-expressing fibroblasts in the presence of polybrene, and d FACS-
sorted IDO-expressing fibroblasts (in the presence of polybrene). Panel
e shows the percentage of mCherry-positive fluorescent cells in the total
cell population studied as detected by flow cytometry. The data shown
are the mean and standard deviation of mCherry-positive cells obtained
from three separate experiments

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analysis (Fig. 2b, panel a). IDO protein level increased in
the presence of polybrene and after sorting. The function-
ality of the overexpressed IDO protein was assessed by
kynurenine assay (Fig. 2b, panel b). The kynurenine
content in the conditioned media of mouse fibroblasts
transduced in the presence of polybrene increased approxi-
mately twofold when compared with that of control with no
polybrene treatment (P<0.01, n=3). This finding revealed
that polybrene significantly enhanced the transduction
efficiency in primary mouse fibroblasts as well as the IDO
protein and its enzymatic activity.
Efficient Stable Expression of IDO 1113.2.1 Analysis of Improvement of Lentiviral Vector
Transduction by Flow Cytometry
To maximize the chances for successful transplantation and
reduce the risk of immunorejection, it would be advanta-
geous to have a highly pure population of IDO-expressing
cells. By FACS, we sorted the IDO–mCherry fluorescent
protein-expressing cells (Fig. 2c). Panel a of Fig. 2c shows
that there is less than 0.02% of autofluorescent cells in the
negative-cell population. As shown in panels b and c of
Fig. 2c, treatment of IDO-lentiviral vector-transduced cells
by polybrene increased the number of mCherry-positive
cells by tenfold. These cells were then gated and sorted by
FACS. Figure 2c, panel d, shows that more than 95% of the
cell population after sorting were expressing IDO, and this
was confirmed by flow cytometry, fluorescence microscopy,
and kynurenine assay. The transduction efficiency was shown
aspercentageofmCherry-positivefluorescentcellsinthetotal
cell population studied (Fig. 2c, panel e). Transduction of
mouse fibroblasts in the presence of polybrene showed a
significant increase in the number of IDO-expressing cells
(P≤0.01, n=3). As a result, we successfully obtained a cell
population that contains more than 95% IDO-expressing
primary fibroblasts (Fig. 2c,p a n e l sd–e).
As efficient gene delivery is a prerequisite for successful
gene therapy, we believe that polybrene significantly
increases lentiviral-mediated delivery of the IDO gene into
target cells and that should make this enzyme a promising
and highly attractive strategy for improving the outcome of
cell and possibly organ transplantation.
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